Teleradiology Assessment of Computerized Tomographs Online Reliability Study (TRACTORS) for Acute Stroke Evaluation

Telemedicine and e-Health

Volumn 9, Issue 3, 2003, Pages 227-233

  Johnston, Karen C ^a,b   Worrall, Bradford B ^a,b,c  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPUTERIZED TOMOGRAPHY; NEUROLOGY; TELEMEDICINE; TISSUE;

THROMBOLYSIS;

RADIOLOGY;

TISSUE PLASMINOGEN ACTIVATOR;

ACUTE DISEASE; ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; EVALUATION; EXPERT SYSTEM; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; PILOT STUDY; PRIORITY JOURNAL; STROKE; TELECOMMUNICATION; VALIDATION PROCESS;

EID: 0142139328     PISSN: 15305627     EISSN: None     Source Type: Journal    
DOI: 10.1089/153056203322502605     Document Type: Article

References (22)

1. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995;333:1581-1587.
2. Johnston SC, et al. Utilization of intravenous tissue-type plasminogen activator for ischemic stroke at academic medical centers: the influence of ethnicity. Stroke 2001;32:1061-1068.
3. Reed SD, Cramer SC, Blough DK, Meyer K, Jarvik JG. Treatment with tissue plasminogen activator and inpatient mortality rates for patients with ischemic stroke treated in community hospitals. Stroke 2001;32:1832-1840.
4. Gage BF, et al. Adverse outcomes and predictors of underuse of antithrombotic therapy in medicare beneficiaries with chronic atrial fibrillation. Stroke 2000;31:822-827.
5. Levine SR, Gorman M. "Telestroke": the application of telemedicine for stroke. Stroke 1999;30:464-469.
6. Shafqat S, Kvedar JC, Guanci MM, Chang Y, Schwamm LH. Role for telemedicine in acute stroke. Feasibility and reliability of remote administration of the NIH stroke scale. Stroke 1999;30:2141-2145.
7. Spilker J, et al. Using the NIH Stroke Scale to assess stroke patients. The NINDS rt-PA Stroke Study Group. J. Neurosci Nurs 1997;29:384-392.
8. Reponen J, et al. Initial experience with a wireless personal digital assistant as a teleradiology terminal for reporting emergency computerized tomography scans. J Telemed Telecare 2000;6:45-49.
9. DeCorato DR, Kagetsu NJ, Ablow RC. Off-hours interpretation of radiologic images of patients admitted to the emergency department: efficacy of teleradiology. AJR Am J Roentgenol 1995;165:1293-1296.
10. Yoo SK, Kim SH, Kim NH, Kim YG. Design of an emergency teleradiology system based on progressive transmission. Yonsei Med J 1995;36:426-437.
11. Schwamm LH, et al. Stroke neurologist review of brain CT via telemedicine accurately identifies candidates for IV t-PA. Stroke 2003;34:280-281 (abstract).
12. Yoo SK, et al. Design of a PC-based multimedia telemedicine system for brain function teleconsultation. Int J Med Inf 2001;61:217-227.
13. Servadei F, et al. Integration of image transmission into a protocol for head injury management: a preliminary report. Br J Neurosurg 2002;16:36-42.
14. Koo CK, Teasdale E, Muir KW. What constitutes a true hyperdense middle cerebral artery sign? Cerebrovasc Dis 2000;10:419-423.
15. von Kummer R, et al. Interobserver agreement in assessing early CT signs of middle cerebral artery infarction. AJNR Am J Neuroradiol 1996;17:1743-1748.
16. Patel SC, et al. Lack of clinical significance of early ischemic changes on computed tomography in acute stroke. J Am Med Assn 2001;286:2830-2838.
17. Tomsick T, et al. Prognostic value of the hyperdense middle cerebral artery sign and stroke scale score before ultraearly thrombolytic therapy. AJNR Am J Neuroradiol 1996;17:79-85.
18. A randomized trial of tirilazad mesylate in patients with acute stroke (RANTTAS). The RANTTAS Investigators. Stroke 1996;27:1453-1458.
19. Fagan SC, et al. Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. NINDS rt-PA Stroke Study Group. Neurology 1998;50:883-890.
20. Wang DZ, Rose JA, Honings DS, Garwacki DJ, Milbrandt JC. Treating acute stroke patients with intravenous tPA. The OSF stroke network experience. Stroke 2000;31:77-81.
21. Hanson SK, et al. Should use of tPA for ischemic stroke be restricted to specialized stroke centers? Stroke 2000;31:313 (abstract).
22. Chalela JA, Kasner SE, Jauch EC, Pancioli AM. Safety of air medical transportation after tissue plasminogen activator administration in acute ischemic stroke. Stroke 1999;30:2366-2368.